SCHEMBL12371588

SCHEMBL12371588

C/C=C\O[C@H]1O[C@H](CO[Si](C)(C)C(C)(C)C)C(C)[C@H](OCCCCCCCCCC)[C@H]1N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13296754 1.00 — —
SCHEMBL12371586 0.93 TNF (0.31) —
SCHEMBL13296756 0.93 TNF (0.31) —
SCHEMBL12371585 0.80 MAPK1 (0.38) —
SCHEMBL12396682 0.80 MAPK1 (0.38) —
SCHEMBL13296743 0.80 MAPK1 (0.38) —
SCHEMBL12371587 0.80 MAPK1 (0.38) —
SCHEMBL12399972 0.80 MAPK1 (0.33) —
SCHEMBL13296750 0.79 GBA1 (0.33) —
SCHEMBL12371589 0.79 GBA1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994154-B2 Substituted liposaccharides useful in the treatment and prevention of endotoxemia Ersai R&D Management Co., Ltd. (JP) 2011-08-09 — — US disclosed
US-20100227835-A1 SUBSTITUTED LIPOSACCHARIDES USEFUL IN THE TREATMENT AND PREVENTION OF ENDOTOXEMIA EISAI R&D MANAGEMENT CO., LTD (JP) 2010-09-09 — — US disclosed
Send feedback